These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9137133)

  • 21. Cholecystokinin and anxiety in normal volunteers: an investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype B antagonist L-365,260.
    Lines C; Challenor J; Traub M
    Br J Clin Pharmacol; 1995 Mar; 39(3):235-42. PubMed ID: 7619662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder.
    Ströhle A; Kellner M; Holsboer F; Wiedemann K
    Am J Psychiatry; 2001 Sep; 158(9):1514-6. PubMed ID: 11532742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholecystokinin-4 and panic.
    Abelson JL; Nesse RM
    Arch Gen Psychiatry; 1990 Apr; 47(4):395. PubMed ID: 2322091
    [No Abstract]   [Full Text] [Related]  

  • 24. Failure of glucagon-like peptide-1 to induce panic attacks or anxiety in patients with panic disorder.
    Strawn JR; D'Alessio DA; Keck PE; Seeley RJ
    J Psychiatr Res; 2008 Jul; 42(9):787-9. PubMed ID: 17888452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder.
    Nutt DJ; Glue P; Lawson C; Wilson S
    Arch Gen Psychiatry; 1990 Oct; 47(10):917-25. PubMed ID: 2171449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cholecystokinin antagonists: anxiolytic drugs of the future].
    Bourin M; Bradwejn J
    Pathol Biol (Paris); 1992 Mar; 40(3):215-7. PubMed ID: 1608663
    [No Abstract]   [Full Text] [Related]  

  • 27. Response to 5% carbon dioxide in children and adolescents: relationship to panic disorder in parents and anxiety disorders in subjects.
    Pine DS; Klein RG; Roberson-Nay R; Mannuzza S; Moulton JL; Woldehawariat G; Guardino M
    Arch Gen Psychiatry; 2005 Jan; 62(1):73-80. PubMed ID: 15630075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rethink the panic disorder].
    Amami O; Aloulou J; Siala M; Aribi L
    Encephale; 2010 Apr; 36(2):100-4. PubMed ID: 20434625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anxiety neurosis--avoidant behavior--depression. A comparison between panic disorder and generalized anxiety disorder].
    Biebl W; Deisenhammer EA; Lehofer M; Muigg W; Posch C; Zeilerbauer J
    Psychother Psychosom Med Psychol; 1993 Jan; 43(1):10-4. PubMed ID: 8441796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laboratory response of patients with panic and obsessive-compulsive disorders to 35% CO2 challenges.
    Perna G; Bertani A; Arancio C; Ronchi P; Bellodi L
    Am J Psychiatry; 1995 Jan; 152(1):85-9. PubMed ID: 7802126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An examination of recent non-clinical panic attacks, panic disorder, anxiety sensitivity, and emotion regulation difficulties in the prediction of generalized anxiety disorder in an analogue sample.
    Tull MT; Stipelman BA; Salters-Pedneault K; Gratz KL
    J Anxiety Disord; 2009 Mar; 23(2):275-82. PubMed ID: 18804947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortisol response during different anxiogenic challenges in panic disorder patients.
    Targum SD
    Psychoneuroendocrinology; 1992 Oct; 17(5):453-8. PubMed ID: 1484913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pentagastrin test for anxiety--psychophysiology and personality.
    Radu D; Ahlin A; Svanborg P; Lindefors N
    Psychopharmacology (Berl); 2003 Mar; 166(2):139-45. PubMed ID: 12529809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Symptom differences in major depression, dysthymia, panic disorder, and generalized anxiety disorder.
    Clark DA; Beck AT; Beck JS
    Am J Psychiatry; 1994 Feb; 151(2):205-9. PubMed ID: 8296890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholecystokinin and panic disorder: past and future clinical research strategies.
    Bradwejn J; Koszycki D
    Scand J Clin Lab Invest Suppl; 2001; 234():19-27. PubMed ID: 11713976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pentagastrin has panic-inducing properties in obsessive compulsive disorder.
    de Leeuw AS; Den Boer JA; Slaap BR; Westenberg HG
    Psychopharmacology (Berl); 1996 Aug; 126(4):339-44. PubMed ID: 8878350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specificity of panic response to CO(2) inhalation in panic disorder: a comparison with major depression and premenstrual dysphoric disorder.
    Kent JM; Papp LA; Martinez JM; Browne ST; Coplan JD; Klein DF; Gorman JM
    Am J Psychiatry; 2001 Jan; 158(1):58-67. PubMed ID: 11136634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anxiogenic effects of the CCK(B) agonist pentagastrin in humans and dose-dependent increase in plasma C-peptide levels.
    Radu D; Ahlin A; Svanborg P; Lindefors N
    Psychopharmacology (Berl); 2002 Jun; 161(4):396-403. PubMed ID: 12073167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ataque de nervios and panic disorder.
    Liebowitz MR; Salmán E; Jusino CM; Garfinkel R; Street L; Cárdenas DL; Silvestre J; Fyer AJ; Carrasco JL; Davies S
    Am J Psychiatry; 1994 Jun; 151(6):871-5. PubMed ID: 8184996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of pentagastrin and the cold pressor test on the acoustic startle response and pupillary function in man.
    Tavernor SJ; Abduljawad KA; Langley RW; Bradshaw CM; Szabadi E
    J Psychopharmacol; 2000; 14(4):387-94. PubMed ID: 11198057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.